Allogene Therapeutics, Inc. (ALLO)

NASDAQ: ALLO · Real-Time Price · USD

1.190

-0.010 (-0.83%)

At close: Jul 3, 2025, 1:00 PM

1.170

-0.020 (-1.68%)

After-hours: Jul 3, 2025, 4:56 PM EDT

Allogene Therapeutics Market Cap

Allogene Therapeutics has a market cap or net worth of $260.29 million as of July 3, 2025. Its market cap has decreased by -45.80% in one year.

Market Cap

260.29M

Enterprise Value

69.17M

1-Year Change

-45.80%

Ranking

#3538

Market Cap Chart

Since October 11, 2018, Allogene Therapeutics's market cap has decreased from $2.88B to $260.29M, a decrease of -90.96%. That is a compound annual growth rate of -30.03%.

Market Cap History

Date	Market Cap	% Change
Jul 3, 2025	260.29M	-41.72%
Dec 31, 2024	446.60M	-17.32%
Dec 29, 2023	540.17M	-40.45%
Dec 30, 2022	907.08M	-57.34%
Dec 31, 2021	2.13B	-39.95%
Dec 31, 2020	3.54B	11.80%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	700.84B
Johnson & Johnson	375.37B
AbbVie	334.34B
Novo Nordisk	316.33B
UnitedHealth Group	279.90B
Novartis AG	242.35B
Abbott Laboratories	233.90B
AstraZeneca	218.65B

Market Cap Rankings